Skip to main content
TipRanks
Go Ultimate75% OFF

PT Ashmore Asset Management Indonesia Tbk (AMOR) Ratios

PT Ashmore Asset Management Indonesia Tbk Ratios

ID:AMOR's free cash flow for Q1 2026 was Rp44.96B. For the 2026 fiscal year, ID:AMOR's free cash flow was decreased by Rp-10.00M and operating cash flow was Rp44.97B. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio61.142.466.066.946.02
Quick Ratio61.142.466.066.946.02
Cash Ratio37.921.913.402.952.88
Solvency Ratio0.700.711.391.381.47
Operating Cash Flow Ratio12.130.711.851.722.03
Short-Term Operating Cash Flow Coverage0.000.0035.190.000.00
Net Current Asset ValueRp 81.14BRp 122.24BRp 274.69BRp 265.70BRp 282.95B
Leverage Ratios
Debt-to-Assets Ratio0.020.030.040.050.05
Debt-to-Equity Ratio0.030.040.050.060.06
Debt-to-Capital Ratio0.030.040.040.050.06
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.441.391.261.241.27
Debt Service Coverage Ratio175.3592.4221.4494.85106.15
Interest Coverage Ratio197.90108.96122.32108.68124.06
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share3.725.256.718.069.24
Net Debt to EBITDA-1.10-2.07-1.67-1.03-1.00
Profitability Margins
Gross Profit Margin54.66%37.96%40.73%48.85%53.10%
EBIT Margin27.89%28.60%32.93%36.25%38.67%
EBITDA Margin29.31%30.56%33.95%37.48%39.83%
Operating Profit Margin26.84%28.60%32.93%34.45%36.87%
Pretax Profit Margin27.75%33.44%40.46%35.93%38.38%
Net Profit Margin22.22%27.15%32.48%28.52%30.10%
Continuous Operations Profit Margin22.22%27.15%32.48%28.52%30.10%
Net Income Per EBT80.08%81.18%80.26%79.36%78.42%
EBT Per EBIT103.38%116.93%122.88%104.31%104.08%
Return on Assets (ROA)20.01%18.54%27.92%25.69%30.14%
Return on Equity (ROE)28.78%25.72%35.19%31.86%38.28%
Return on Capital Employed (ROCE)24.37%25.73%33.47%35.84%43.70%
Return on Invested Capital (ROIC)19.36%20.66%26.61%28.44%34.27%
Return on Tangible Assets20.24%18.82%28.48%26.10%30.15%
Earnings Yield12.05%6.23%6.18%3.75%3.95%
Efficiency Ratios
Receivables Turnover4.775.448.758.9610.17
Payables Turnover15.7722.6419.1916.3015.82
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover53.8925.7524.1820.1220.48
Asset Turnover0.900.680.860.901.00
Working Capital Turnover Ratio2.211.241.121.101.39
Cash Conversion Cycle53.3450.9922.6718.3712.83
Days of Sales Outstanding76.4867.1141.6940.7635.91
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding23.1416.1219.0222.3923.08
Operating Cycle76.4867.1141.6940.7635.91
Cash Flow Ratios
Operating Cash Flow Per Share18.8730.0248.5337.5855.75
Free Cash Flow Per Share18.8629.9048.2337.1655.63
Dividend Paid and CapEx Coverage Ratio0.600.721.110.771.10
Capital Expenditure Coverage Ratio3784.91258.68159.7590.80460.01
Operating Cash Flow Coverage Ratio5.416.087.684.956.40
Operating Cash Flow to Sales Ratio0.110.250.330.260.31
Free Cash Flow Yield5.93%5.70%6.26%3.33%4.12%
Valuation Ratios
Price-to-Earnings (P/E) Ratio8.3016.0616.1926.6925.29
Price-to-Sales (P/S) Ratio1.844.365.267.617.61
Price-to-Book (P/B) Ratio2.394.135.708.509.68
Price-to-Free Cash Flow (P/FCF) Ratio16.8617.5615.9630.0024.27
Price-to-Operating Cash Flow Ratio16.8617.4915.8629.6724.21
Price-to-Earnings Growth (PEG) Ratio0.48-0.511.17-1.231.33
Enterprise Value Multiple5.2012.2013.8219.2718.12
Enterprise Value579.31B994.10B1.52T2.34T2.84T
EV to EBITDA5.2012.2013.8219.2718.12
EV to Sales1.523.734.697.227.22
EV to Free Cash Flow13.9215.0114.2528.4823.00
EV to Operating Cash Flow13.9114.9514.1628.1622.95
Tangible Book Value Per Share130.95124.43131.74128.54137.61
Shareholders’ Equity Per Share133.08127.08135.11131.13139.44
Tax and Other Ratios
Effective Tax Rate0.200.190.200.210.22
Revenue Per Share172.37120.40146.41146.51177.35
Net Income Per Share38.3032.6847.5541.7853.38
Tax Burden0.800.810.800.790.78
Interest Burden1.001.171.230.990.99
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.040.040.030.030.02
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.490.921.020.901.04

Currency in IDR